Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Looking forward
View:
Post by goldtech on Jan 09, 2022 1:36pm

Looking forward

After years of Elliott and Gene screwing the shareholders we can look forward to some changes. First thing we need to eliminate Elliott totally, no consultant or any association with Promis, then his buddy Gene must go as well. This board needs some credible Directors, Wyman, Gregory, Kirwin and the do nothing head bobbers to Gene must be punted. Now we have pending news on serology and numerous antibodies to joint venture. This news is waiting to be released in this quarter, but Gene wants a rollback before the stock has a chance to appreciated, he is always a detriment to this company. Lots to happen this quarter but with an incompetent corrupt management I will tread cautiously.
Comment by DavidKingCanada on Jan 09, 2022 6:12pm
Eugene is CEO and Elliot is not listed anywhere on their Website. There is no way Eugene will step down as CEO in 2022. The Company is headed in the right direction. 
Comment by M101 on Jan 10, 2022 12:59pm
Agreed. So far as shareholders have been informed, we now have "President and Special Consultant to the CEO" who appears nowhere on the web pages, except in his former PR capacity videos, and who's fees will no doubt not be itemized in future financial statements.  It's naked cronyism, it's embarrassing, but it's everywhere.    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities